The Current State of Molecular Testing and Predictive Biomarkers in Gastrointestinal Malignancies

In this engaging satellite symposium, expert faculty discuss current best practice for molecular testing of biomarkers to guide treatment decisions for patients with GI malignancies.
Pashtoon Kasi, MD
John L. Marshall, MD
Michael J. Pishvaian, MD, PhD

Downloadable Slidesets

Download these slides from our 2020 ASCO-GI live satellite symposium on biomarkers to review the current state of biomarker testing and liquid biopsy using cell-free circulating tumor DNA.

Pashtoon Kasi, MD John L. Marshall, MD Released: January 23, 2020

Download these slides from our 2020 ASCO-GI live satellite symposium on histology-agnostic biomarkers in advanced GI cancers including MMR/MSI and NTRK fusions.

Pashtoon Kasi, MD John L. Marshall, MD Released: January 23, 2020

Download these slides from our 2020 ASCO-GI live satellite symposium on biomarker-driven treatment of advanced gastrointestinal malignancies including colorectal cancer and pancreatic cancer.

Pashtoon Kasi, MD Michael J. Pishvaian, MD, PhD Released: January 23, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Array BioPharma Inc.
Bayer HealthCare Pharmaceuticals Inc.
Merck Sharp & Dohme Corp

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue